Table 1.
HFNC (43) | CPAP (41) | P-value | |
---|---|---|---|
CHARACTERISTIC | |||
Age, months, median (range) | 3 (2–11) | 4 (1–11) | p = 0.993 |
Distribution—no. (%) ≤12 mo |
36 (84) | 32 (78) | |
>12 mo | 7 (16) | 9 (22) | |
Weight, kg, median (range) | 6 (5–9) | 6.5 (4.5–9.25) | p = 0.911 |
Female sex n (%) | 19 (44) | 18 (43) | p = 0.979 |
Symptom duration, days, median (range) | 7 (4–8) | 5 (4–8.5) | p = 0.414 |
HR, min, mean (sd) | 153.6 ± 17.1 | 147 ± 15.5 | p = 0.111 |
RR, min, mean (sd) | 59.8 ± 7.4 | 57.2 ± 9.2 | p = 0.151 |
PaO2, mmHg, mean (sd) | 54.3 ± 7.8 | 53.3 ± 9.1 | p = 0.584 |
PaCO2, mmHg, median (range) | 42 (37–49) | 42 (38–48) | p = 0.661 |
SPO2, % median (range) | 90 (88–91) | 90 (87–91) | p = 0.856 |
PaO2 / FiO2, mean (sd) | 217.1 ± 31.1 | 213.1 ± 36.2 | p = 0.584 |
PH, mean (sd) | 7.38 ± 0.06 | 7.38 ± 0.07 | p = 0.895 |
Imaging diagnosis, n (%) | 43 (100) | 41 (100) | — |
Congenital heart disease, n (%) | 5 (12) | 7 (17) | p = 0.476 |
Viral cause, n (%) | 28 (65) | 20 (49) | p = 0.130 |
Comparison of general data on baseline characteristics between the two groups[cases (%). Values are expressed as mean (SD) ±SD or numbers (%),No differences were found between the two groups.